D.C. Mun. Regs. tit. 16, § 3634
3634.1 Violation of any of the following provisions shall be a Class 1 Infraction:
before the project is implemented without the prior review and approval by SHPDA of a new CON).
3634.2 Violation of any of the following provisions shall be a Class 2 Infraction:
(a) Section 10(j) of the Act, effective April 9, 1997 (D.C. Law 11-191; D.C. Official Code § 44-409(j)) (beginning operation of the bed, health care facility, or health service approved in a CON before the SHPDA has conducted a review to determine compliance with the CON requirements);
(b) Section 12(d) of the Act, effective April 9, 1997 (D.C. Law 11-191; D.C. Official Code § 44-411(d)) (any transfer, assignment, or other disposition of 10% of the stock or voting rights thereunder of a corporation or other entity which is the operator of a health care facility, or any transfer, assignment, or other disposition of the stock or voting rights thereunder of the corporation which results in the ownership or control of more than 10% of the stock or voting rights thereunder of the corporation, by any person, when that corporation or entity holds a current CON, without the prior review and approval by SHPDA of a new CON);
(c) 22-B DCMR § 4000.2 (undertaking any activity for which a CON is required if the original term of the CON has expired and the person has not obtained an extension of the CON or the SHPDA Director has revoked the CON);
(d) 22-B DCMR § 4005.3 (failure of a CON holder to request the SHPDA Director's approval for a proposed change in the project budget that will result in an expenditure that is equal to or greater than one hundred and twenty-five per cent (125%) of the approved capital expenditure specified in the CON);
(e) 22-B DCMR § 4005.3 (commencing work on proposed changes to a project or portion thereof where the proposed changes would cause the capital expenditure for the proposed changes would equal or exceed twenty-five per cent (25%) of the maximum capital expenditure in the approved CON without review and approval of the revised capital expenditure by the SHPDA Director);
(f) 22-B DCMR § 4005.4 (failure of a CON holder to submit an application for a new CON when the proposed change in the project would cause an increase of the capital expenditure for the project in an amount that exceeds the proposed budget by fifty percent (50%) of the approved capital expenditure specified in the CON without review and approval of the revised capital expenditure by the SHPDA Director);
(g) 22-B DCMR § 4005.10 (failure of a CON holder to report to SHPDA each proposed change to the specifications in the approved CON);
(h) 22-B DCMR § 4005.15 (failure of a CON holder to report to SHPDA each proposed change to a completed project involving a capital expenditure when the change is proposed within two (2) years after the date the activity for which the expenditure was approved is undertaken);
(i) 22-B DCMR § 4006.6 (commencing operation of an approved project or phase of an approved project prior to the issuance by SHPDA of a Letter of Completion for the approved project or approved phase of a project); or
(j) 22-B DCMR § 4100.1 (failure to notify SHPDA in writing of the establishment of a new institutional health service solely for research).
3634.3 Violation of any of the following provisions shall be a Class 3 Infraction:
(a) Section 6(a) of the Act, effective April 9, 1997 (D.C. Law 11-191; D.C. Official Code § 44-405(a)) (failure to submit to SHPDA any required data related to the utilization, management, and financing of health services, including data on utilization of health services, cost of services, charges of services, patient demographic, characteristic information, and data related to the annual level of uncompensated care provided); or
(b) 22-B DCMR § 4008.1 (failure to make quarterly progress reports to SHPDA).
3634.4 Each day of a continuing violation shall constitute a separate offense.
SOURCE: Final Rulemaking published at 52 DCR 5045 (May 27, 2005); as amended by Final Rulemaking published at 69 DCR 015553 (December 30, 2022).